Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: Evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback

European Journal of Endocrinology

Volumn 155, Issue 4, 2006, Pages 513-522

  Rochira, Vincenzo ^a   Zirilli, Lucia ^a   Genazzani, Alessandro D ^a   Balestrieri, Antonio ^a   Aranda, Claudio ^c   Fabre, Bibiana ^c   Antunez, Paula ^b   Diazzi, Chiara ^a   Carani, Cesare ^a   Maffei, Laura ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Consultorios Asociados de Endocrinologia ^*  (Argentina)

^c Tomografia Computada Buenos Aires TCBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AROMATASE; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADORELIN; GONADOTROPIN; INHIBIN B; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; ENZYME DEFICIENCY; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; FOLLITROPIN BLOOD LEVEL; GONADORELIN RELEASE; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MATURATION; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROVOCATION TEST; PULSATILE HORMONE RELEASE; SPERMATOGENESIS; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; AROMATASE; ESTROGENS; FEEDBACK, BIOCHEMICAL; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; GONADS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LUTEINIZING HORMONE; MALE; MODELS, BIOLOGICAL; PULSATILE FLOW; RESEARCH DESIGN;

EID: 33750273487     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02254     Document Type: Article

References (55)

1. Finkelstein IS, Whitcomb RW, O'Dea LS, Longcope C, Schoenfeld DA & Crowley WF Jr. Sex steroid control of gonadotropin secretion in the human male. I. Effect of testosterone administration in normal and gonadotropin-releasing hormone-deficient men. Journal of Clinical Endocrinology and Metabolism 1991 73 609-620.
2. Finkelstein JS, O'Dea LS, Whitcomb RW & Crowley WF. Sex steroid control of gonadotropin secretion in the human male. II. Effect of estradiol administration in normal and gonadotropin-releasing hormone-deficient men. Journal of Clinical Endocrinology and Metabolism 1991 73 621-628.
3. Bagatell CJ, Dahl KD & Bremner WJ. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. Journal of Andrology 1994 15 15-21.
4. Veldhuis JD & Dufau. ML. Estradiol modulates the pulsatile secretion of biologically active luteinizing hormone in man. Journal of Clinical Investigation 1987 80 631-638.
5. Schnorr JA, Bray MJ & Veldhuis JD. Aromatization mediates testosterone's short-term feedback restraint of 24-h endogenously driven and acute exogenous gonadotropin-releasing hormone-stimulated luteinizing hormone and follicle-stimulating hormone secretion in young men. Journal of Clinical Endocrinology and Metabolism 2001 86 2600-2606.
6. Hayes FJ, Seminara SB, Decruz S, Boepple PA & Crowley WF, Jr. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. Journal of Clinical Endocrinology and Metabolism 2000 85 3027-3035.
7. Mauras N, O'Brien KO, Klein KO & Hayes V. Estrogen suppression in males: metabolic effects. Journal of Clinical Endocrinology and Metabolism 2000 85 2370-2377.
8. Wickman S & Dunkel L. Inhibition of P450 aromatase enhances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E. Journal of Clinical Endocrinology and Metabolism 2001 86 4887-4894.
9. Taxel P, Kennedy DG, Fall PM, Willard AK, Clive JM & Raisz LG. The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. Journal of Clinical Endocrinology and Metabolism 2001 86 2869-2874.
10. Leder BZ, Rohrer JL, Rubin SD, Gallo J & Longcope C. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. Journal of Clinical Endocrinology and Metabolism 2004 89 1174-1180,
11. Faustini-Fustini M, Rochira V & Carani C. Cestrogen deficiency in men: where are we today? European Journal of Endocrinology 1999 140 111-129.
12. Rochira V, Balestrieri A, Madeo B, Spaggiari A & Carani C. Congenital estrogen deficiency in men: a new syndrome with different phenotypes; clinical and therapeutic implications in men. Molecular and Cellular Endocrinology 2002 193 19-28.
13. Carand C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS & Simpson ER. Effect of testosterone and estradiol in a man with aromatase deficiency. New England Journal of Medicine 1997 337 91-95.
14. Maffei L, Murata Y, Rochtra V, Tubert G, Aranda, C, Vazquez M, Clyne CD, Davis S, Simpson ER & Carani C. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. Journal of Clinical Endocrinology and Metabolism 2004 89 61-70,
15. Rochira V, Balestrieri A, Faustini-Fustini M, Borgato S, Beck-Peccoz P & Carani C. Pituitary function in a man with congenital aromatase deficiency: effect of different doses of transdermal estradiol on basal and stimulated pituitary hormones. Journal of Clinical Endocrinology and Metabolism 2002 87 2857-2862.
16. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB & Korach KS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England Journal of Medicine 1994 331 1056-1061.
17. Vanderschueren D & Bouillon R. Editorial: estrogen deficiency in men is a challenge for both the hypothalamus and pituitary. Journal of Clinical Endocrinology and Metabolism 2000 85 3024-3026.
18. Rochira V, Faustini-Fustini M, Balestrieri A & Carani C. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. Journal of Clinical Endocrinology and Metabolism 2000 85 1841-1845.
19. Genazzani AD, Petraglia F, Benatti R, Montanini V, Atgeri I, Volpe A & Genazzani AR. LH secretory burst duration is independent from LH, prolactin or gonadal steroid plasma levels in amennorheic women. Journal of Clinical Endocrinology and Metabolism 1991 72 1220-1225.
20. Oerter KE, Guardabasso V & Rodbard D. Detection and characterization of peaks and estimation of instantaneous secretory rate for episodic pulsatile hormone secretion. Computers and Biomedical Research 1986 19 170-191.
21. Genazzani AD & Rodbard D. Evaluation of methods for detection of pulsatile hormone secretion: sensitivity vs specificity. Acta Endocrinologica (Copenhagen) 1991 124 295-306.
22. Thorner MO, Vance ML, Laws ER Jr, Horvath E & Kovacs K. The anterior pituitary. In Williams Textbook of Endocrinology, 9th edn, ch 9, pp 249-340. Eds JD Wilson, DW Foster, HM Kronenberg & PR Larsen. Philadelphia, PA: WB Saunders Co, 1998.
23. Wu FCW, Taylor PL & Sellar RE. LHRH pulse frequency in normal and infertile men. Journal of Endocrinology 1989 123 149-158.
24. Santen RJ & Bardin CW. Episodic lutinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms. Journal of Clinical Investigation 1973 52 2617-2628.
25. De Martino MU, Pastore R, Caprio M, Frajese G & Fabbri A. Dynamic testing in the evaluation of male gonadal function. Journal of Endocrinological Investigation 2003 26 107-113.
26. Morishima A, Grumbach MM, Simpson ER, Fisher C & Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism 1995 80 3689-3698.
27. Bilezikian JP, Morishima A, Bell J & Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. New England Journal of Medicine 1998 339 599-603.
28. Herrman BL, Saller B, Janssen OE, Gocke P, Bockish A, Sperling H, Mann K & Broecker M. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. Journal of Clinical Endocrinology and Metabolism 2002 87 5476-5484.
29. Rochira V, Granata ARM, Madeo B, Zirilli L, Rossi G & Carani C. Estrogens in males: what have we learned in the last 10 years? Asian Journal of Andrology 2005 7 3-20.
30. Genazzani AD, Forti G, Maggi M, Milloni M, Cianfanelli E Guardabasso V, Toscano V, Serio M & Rodbard D. Pulsatile secretion of LH in agonadal men before and during testosterone replacement therapy. Journal of Endocrinological Investigation 1990 10 777-786.
31. van Bergeijk L, Gooren LJG, van Kessel H & Sassen AM. Effects of continuous LHRH infusion on plasma levels of LH and FSH in males, before and after oestrogen or anti-oestrogen treatment. Hormone and Metabolic Research 1986 18 558-564.
32. Shozu M, Sebastian S, Takayama K, Hsu WT, Schultz RA, Neely K, Bryant M & Bulun SE. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. New England Journal of Medicine 2003 348 1855-1865.
33. Hayes FJ, Decruz S, Seminara SB, Boepple PA & Crowley WF, Jr. Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. Journal of Clinical Endocrinology and Metabolism 2001 86 53-58.
34. Griffin JE & Wilson ID. Disorders of the testes and the male reproductive tract. In Williams Textbook of Endocrinology, 10th edn, pp 706-769. Eds PR Larsen, HM Kronenberg, S Melmed & KS Polonsky. Philadelphia, PA: Saunders, 2003.
35. Von Eckardstein S, Simom M, Bergmann M, Weinbauer GF, Gassner P, Shepers AG & Nieschlag E. Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. Journal of Clinical Endocrinology and Metabolism 1999 84 2496-2501.
36. Andersson AM, Petersen JH, Jørgensen N, Jensen TK & Skakkebæk NE. Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men. Journal of Clinical Endocrinology and Metabolism 2004 89 2873-2879.
37. Meachem SJ, Nieschlag E & Simoni S. Inhibin B in male reproduction: pathophysiology and clinical relevance. European Journal of Endocrinology 2001 145 561-571.
38. Tena-Sempere M, Gonzalez LC, Pinilla L, Huhtaniemi I & Aguilar E. Neonatal imprinting and regulation of estrogen receptor alpha and beta mRNA expression by estrogen in the pituitary and hypothalamus of the male rat. Neuroendocrinology 2001 73 12-25.
39. Sanchez-Criado JE, Bellido C, Aguilar R & Garrido-Gracia JC. A paradoxical inhibitory effect of oestradiol-17beta on GnRH self-priming in pituitaries from tamoxifen-treated rats. Journal of Endocrinology 2005 186 43-49.
40. Matagne V, Rasier G, Lebrethon MC, Gérard A & Bourguignon JP. Estradiol stimulation of pulsatile gonadotropin-releasing hormone secretion in vitro: correlation with perinatal exposure to sex steroids and induction of sexual precocity in vivo. Endocrinology 2004 145 2775-2783.
41. Fraser MO, Arslan M & Plant AM. Androgen and estrogen treatment, alone or in combination, differentially influences bone maturation, and hypothalamic mechanisms that time puberty in the male rhesus monkey (Macaca mulatta). Pediatric Research 2005 57 141-148.
42. Deladoëy J, Flück C, Bex M, Yoshimura N, Harada N & Mullis PE. Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy. Journal of Clinical Endocrinology and Metabolism 1999 84 4050-4054.
43. Bouillon R, Bex M, Vanderschueren D & Boonen S. Estrogens are essential for male pubertal periosteal bone expansion. Journal of Clinical Endocrinology and Metabolism 2004 89 6025-6029.
44. Plant TM. Puberty in primates. In The Physiology of Reproduction, The Physiology of Reproduction, 2nd edn, vol 2, pp 453-485. Eds E Knobil & JD Neill. New York: Raven Press, 1994.
45. Quigley CA. The androgen receptor: physiology and pathophisiology. In Testosterone: Action-Deficiency-Substitution, 2nd edn, pp 33-106. Eds E Nieschlag & HM Behre. Philadelphia, PA: Springer, 1998.
46. Herbison AE. Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. Endocrine Reviews 1998 19 302-330.
47. Swaab DF. The complex effects of sex hormones on the brain it all depends on the species, sex, age and cell type. XX versus XY 2003 1 3-4.
48. Carani C, Rochira. V, Faustini-Fustim M, Balestrieri A & Granata ARM. Role of estrogen in male sexual behaviour: insights from the natural model of aromatase deficiency. Clinical Endocrinology 1999 51 517-524.
49. Nwagwu MO, Baines H, Kerr JB & Ebling FJ. Neonatal androgenization of hypogonadal (hpg) male mice does not abolish estradiol-induced FSH production and spermatogenesis. Reproductive Biology and Endocrinology 2005 3 48.
50. Mc Ardle CA, Schomerus E, Gröner I & Poch A. Estradiol regulates gonadotropin-releasing hormone receptor number, growth and inositol phosphate production in a T3-1 cells. Molecular and Cellular Endocrinology 1992 87 95-103.
51. Kaiser UB, Conn PM & Chin WW. Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocrine Reviews 1997 18 46-70.
52. Sullivan KA, Witkin JW, Ferin M & Silverman AJ. Gonadotropin-releasing hormone neurons in the rhesus macaque are not immunoreactive for the estrogen receptor. Brain Research 1995 685 198-200.
53. Hrabovszky E, Steinhauser A, Barabas K, Shughrue PJ, Petersen SL, Merchenthaler I & Liposits Z. Estrogen receptor-beta immunoreactivity in luteinizing hormone-releasing hormone neurons of the rat brain. Endocrinology 2001 142 3261-3264.
54. Rochira V, Balestrieri A, Madeo B, Baraldi E, Faustini-Fustini M, Granata AR & Carani C. Congenital estrogen deficiency: in search of the estrogen role in human male reproduction. Molecular and Cellular Endocrinology 2001 178 7-115.
55. Carani C, Granata AR, Rochira V, Caffagni G, Aranda C, Antunez P & Maffei LE. Sex steroids and sexual desire in a man with a novel mutation of aromatase gene and hypogonadism. Psychoneuroendocrinology 2005 30 413-417.